Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2015-04-07 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于召开2014年度股东大会的提示性公告
AGM Information Classification · 100% confidence The document is a detailed announcement about the convening of the 2014 Annual General Meeting (AGM) of 三诺生物传感股份有限公司. It includes information on the meeting date, time, venue, agenda items to be discussed and voted on, registration procedures, voting methods (including online voting), and proxy forms. The document does not contain the actual annual report or financial statements but rather serves as a notice to shareholders about the upcoming AGM and the related procedural details. The document length is 7312 characters, which is substantial but the content is clearly an announcement for the AGM rather than the AGM materials or the annual report itself. Therefore, the appropriate classification is AGM Information (AGM-R).
2015-04-07 Chinese
关于重大事项停牌进展公告
Regulatory Filings Classification · 95% confidence The document is titled as an announcement regarding the progress of a trading suspension due to a significant matter that may affect the stock price. It references regulatory compliance with the Shenzhen Stock Exchange rules and details the continuation of the stock suspension. The document is short (755 characters) and serves as a formal notice to investors about the suspension status and ongoing disclosure obligations. It does not contain financial data, audit information, or detailed report content. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance notices that do not fit other specific categories.
2015-03-30 Chinese
关于公司再次通过高新技术企业认定的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's re-certification as a high-tech enterprise, including details about the tax benefits and certification validity. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory announcement about a certification status and related tax policy, not a financial report or meeting material. The document length is short (667 characters), and it is an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2015-03-27 Chinese
中信证券股份有限公司关于公司2014年度持续督导跟踪报告
Audit Report / Information Classification · 95% confidence The document is titled '中信证券股份有限公司 关于三诺生物传感股份有限公司 2014 年度持续督导跟踪报告' which translates to 'CITIC Securities Co., Ltd. 2014 Annual Continuous Supervision Tracking Report on Sinocare Bio-sensing Co., Ltd.' The content includes detailed supervision activities by the sponsor (CITIC Securities) over the company during 2014, including review of quarterly and annual reports, governance, fundraising supervision, internal controls, and regulatory compliance. It also lists issues found and measures taken, shareholder commitments, and other regulatory matters. The document is a detailed report on ongoing sponsor supervision rather than a full annual report or audit report. It is not a brief announcement or a certification letter. The length (6562 characters) and detailed content confirm it is a substantive report. This type of document corresponds to an Audit Report / Information (AR) category, as it is a standalone supervisory report related to regulatory compliance and sponsor oversight, not the full annual report (10-K) or other categories. Therefore, the correct classification is AR with high confidence. FY 2014
2015-03-23 Chinese
关于重大事项停牌的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the suspension of trading (停牌) of the company's stock due to a major pending matter that could affect the stock price. It states the stock will be suspended starting from a specific date and that the company will disclose further information once the matter is clarified. There are no financial statements, detailed financial data, or report contents included. The document is an official notice about a trading halt related to a significant event, which fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into more specific categories like Capital/Financing Update or Delisting Announcement. The document length is short (562 characters), and it is clearly an announcement rather than a full report or detailed filing.
2015-03-23 Chinese
第二届董事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 19th meeting of the second board of directors of the company 三诺生物传感股份有限公司. It includes approvals of the 2014 annual board work report, general manager's report, financial statements, annual report, profit distribution plan, and various governance and internal control policies. It also mentions that these resolutions will be submitted to the 2014 annual shareholders' meeting for approval. The document is dated March 17, 2015, and references the 2014 fiscal year. The content is primarily about board meeting decisions and governance matters rather than the full annual report itself. The document is over 10,000 characters, indicating it is not a brief announcement but a full meeting resolution document. This fits best with the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. It is not the full Annual Report (10-K) itself, nor a simple announcement of a report publication (RPA).
2015-03-16 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.